Đăng ký: VietNam News
| On April 16th, the Slovenian health agency said a Slovenian citizen was suspected of being infected with Ebola. The suspected patient had recently returned from an Ebola-affected region of Africa with a severe fever. The patient was tested in the state of the art micro-biology institute of the Slovenian health agency. The Ljubljana University Medical Centre (UKC), one of the largest hospitals in central Europe, will offer the best possible care to those believed to be infected by the Ebola virus, according to UKC medical chief, Franc Strle. Slovenia has been on alert to treat Ebola patients since the World Health Organisation (WHO) appealed to the world to curb the spread of the epidemic rampant in West Africa in 2014. On April 14th, a clinical trial of an Ebola vaccine called rVSV-ZEBOV was launched in the West African nation of Sierra Leone, the U.S. Centers for Disease Control and Prevention said. The rVSV-ZEBOV candidate vaccine uses a vesicular stomatitis virus carrying a non-infectious Ebola virus gene. The vaccine cannot cause the Ebola virus disease but can potentially stimulate an immune response to protect against it. The WHO confirmed that the number of deaths caused by the deadliest outbreak of Ebola in history has reached over 10,600 from more than 25,700 cases of infection mainly in Liberia, Sierra Leone and Guinea./. |